PSC
Principal U.S. Small-Cap ETF
Set alert
68.37 USD -1.16 -1.67%
67.83 Day range 69.56
53.86 52-week range 70.76
- YTD
- +18.43%
- 1 year
- +21.20%
- Open
- 69.56
- Prev close
- 69.53
- Mkt cap
- 1.22B
- Vol
- 102.36K
- Avg vol
- 133.19K
- EPS
- 4.05
- P/E
- 16.89
- Div yield
- 0.00%
More statistics
- Low
- 67.83
- High
- 69.56
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 68.08
- 200-d avg
- 64.76
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 16.89
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 68.08
- 200-day average
- 64.76
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Principal U.S. Small-Cap ETF
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of U.S. companies with small market capitalizations. For this fund, companies with small market capitalizations are those with market capitalizations within the range of companies comprising the Russell 2000 Index.
News
- Woodside Energy Third Quarter Report for Period Ended 30 September 2026
- Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases
- Zeta Global Expands AI Arsenal With Digital Audience Buyout
- Zeta Global Adds Senso to Its AI Arsenal
- CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
- Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta on September 28, 2026
- Principal U.S. Small-Cap Multi-Factor ETF $PSC Shares Purchased by NewEdge Advisors LLC
- Petronas, PTT units secure approval for new gas contract in Malaysia-Thailand joint area
- Georgia Power's contract with OpenAI approved; Latest approval part of portfolio of large-load contracts delivering approximately $950 million in annual savings beginning in 2029
- Kentucky PSC Approves 482 MW Power Agreement for TeraWulf's Justified Data Campus
Your note
Sign in to keep a note on PSC — it syncs with the Stock Master app.